Neuronal nuclei (NeuN) is a well-recognized “marker” that is detected exclusively in post-
mitotic neurons and was initially identified through an immunological screen to produce …

No treatment currently exists to restore lost neurological function after stroke. A growing
number of studies highlight the potential of stem cell transplantation as a novel therapeutic …

To determine the role of brain‐derived neurotrophic factor (BDNF) in the enhancement of
hippocampal neurogenesis resulting from dietary restriction (DR), heterozygous BDNF …

Ischemic stroke is one of the major health problems worldwide. The only FDA approved anti-
thrombotic drug for acute ischemic stroke is the tissue plasminogen activator. Several …

Cell therapy is emerging as a viable therapy to restore neurological function after stroke.
Many types of stem/progenitor cells from different sources have been explored for their …

Stem cell transplantation has evolved as a promising experimental treatment approach for
stroke. In this review, we address the major hurdles for successful translation from basic …

Transplantation of neural stem cells (NSCs) has been proposed as a therapy for a range of
neurological disorders. To realize the potential of this approach, it is essential to control …

Intraparenchymally transplanted rodent-origin neural and human-origin mesenchymal stem
cells migrate and differentiate in neurological diseases. By intravenously injecting human …

Neuronal loss is a major pathological outcome of many common neurological disorders,
including ischemia, traumatic brain injury, and Alzheimer disease. Stem cell-based …

Stroke has a debilitating effect on the human body and a serious negative effect on society,
with a global incidence of one in every six people. According to the World Health …